• Guy Tsafnat

Don't worry be Skeptic

Evidentli’s mission is to enable faster, more transparent, reproducible evidence. A great example of the need for this is illustrated by a landmark study published 10 years ago this month. It found that the R&D costs of development was not only high (~$1.5B USD) but was rising rapidly which severely impedes innovation, translation of research to practice, and ultimately healthcare. Evidentli’s Piano not only automates and streamlines the production and dissemination of clinical evidence, but also improves the quality of the evidence.

Feeling Skeptical? Good. Contact us to find out more.

Rapidly rising clinical trial costs worry researchers


Level 1 E10 Building

UNSW Sydney

NSW 2052, Australia



©2019 Evidentli